Spots Global Cancer Trial Database for childhood leukemia
Every month we try and update this database with for childhood leukemia cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
PRecISion Medicine for Children With Cancer | NCT03336931 | Childhood Cance... Childhood Solid... Childhood Brain... Childhood Leuke... Refractory Canc... Relapsed Cancer | Molecular profi... | - 21 Years | Sydney Children's Hospitals Network | |
Precision Medicine for Every Child With Cancer | NCT05504772 | Childhood Cance... Childhood Solid... Childhood Brain... Childhood Leuke... Refractory Canc... Relapsed Cancer | Whole Genome Se... RNA seq DNA Methylation Targeted Panel ... High Throughput... Patient Derived... Liquid Biopsy | 0 Years - 25 Years | Australian & New Zealand Children's Haematology/Oncology Group | |
Monitoring and Treatment of Relapsed Leukemia Following Allogeneic Hematopoietic Stem Cell Transplantation in Children | NCT02484261 | Leukemia | Bortezomib Pravastatin | 22 Months - 21 Years | Children's National Research Institute | |
Advanced Translational Research on Childhood Leukemia | NCT04478006 | Childhood Leuke... | RNA-seq whole exon sequ... Cytogenetics te... | - 18 Years | Chinese University of Hong Kong | |
Efficacy/Safety of Frontline Alemtuzumab (Campath, MabCampath) vs Chlorambucil in Patients With Progressive B-Cell Lymphocytic Leukemia | NCT00046683 | B Cell Chronic ... | alemtuzumab | 18 Years - | Sanofi | |
Lymphoproliferative Disorders After Diagnosis of Childhood Acute Lymphoblastic Leukemia/Lymphoma | NCT04055558 | Childhood Leuke... | - 30 Years | Rabin Medical Center | ||
Precision Medicine for Every Child With Cancer | NCT05504772 | Childhood Cance... Childhood Solid... Childhood Brain... Childhood Leuke... Refractory Canc... Relapsed Cancer | Whole Genome Se... RNA seq DNA Methylation Targeted Panel ... High Throughput... Patient Derived... Liquid Biopsy | 0 Years - 25 Years | Australian & New Zealand Children's Haematology/Oncology Group | |
Bendamustine Hydrochloride, Clofarabine, and Etoposide in Treating Younger Patients With Relapsed or Refractory Hematologic Malignancies | NCT01900509 | Hodgkin Lymphom... Non-Hodgkin Lym... Acute Leukemia | Bendamustine Clofarabine Etoposide Etoposide phosp... Dexamethasone | - 21 Years | St. Jude Children's Research Hospital | |
Advanced Translational Research on Childhood Leukemia | NCT04478006 | Childhood Leuke... | RNA-seq whole exon sequ... Cytogenetics te... | - 18 Years | Chinese University of Hong Kong | |
Panobinostat With Fludarabine and Cytarabine for Treatment of Children With Acute Myeloid Leukemia or Myelodysplastic Syndrome | NCT02676323 | Acute Myeloid L... Myelodysplastic... | Panobinostat Fludarabine Cytarabine Intrathecal Tri... Leucovorin | - 24 Years | St. Jude Children's Research Hospital | |
Symptom Clusters in Children With Leukemia | NCT01708421 | Childhood Leuke... | 3 Years - 18 Years | Duke University | ||
Efficacy/Safety of Frontline Alemtuzumab (Campath, MabCampath) vs Chlorambucil in Patients With Progressive B-Cell Lymphocytic Leukemia | NCT00046683 | B Cell Chronic ... | alemtuzumab | 18 Years - | Sanofi | |
Panobinostat With Fludarabine and Cytarabine for Treatment of Children With Acute Myeloid Leukemia or Myelodysplastic Syndrome | NCT02676323 | Acute Myeloid L... Myelodysplastic... | Panobinostat Fludarabine Cytarabine Intrathecal Tri... Leucovorin | - 24 Years | St. Jude Children's Research Hospital | |
Lymphoproliferative Disorders After Diagnosis of Childhood Acute Lymphoblastic Leukemia/Lymphoma | NCT04055558 | Childhood Leuke... | - 30 Years | Rabin Medical Center |